$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical drugs
Medical drugs
Medical drugs-Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Lenvatinib price after medical insurance reimbursement in 2023
2026-02-01 22:25:32
Check Details
Is it effective to take one pill of Lenvatinib a day if I weigh 50kg?
2026-02-01 22:25:32
Check Details
Can imported Lenvatinib be reimbursed?
2026-02-01 22:25:32
Check Details
What should I do if I have an upset stomach after taking Lenvatinib?
2026-02-01 22:25:32
Check Details
How long should I take Lenvatinib?
2026-02-01 22:25:32
Check Details
Lenvatinib combined with PD1 in the treatment of advanced liver cancer
2026-02-01 22:25:32
Check Details
Time to develop high blood pressure while taking Lenvatinib
2026-02-01 22:25:32
Check Details
Acalabrutinib price
2026-02-01 22:25:32
Check Details
How much does a box of Acalabrutinib cost?
2026-02-01 22:25:32
Check Details
Acalabrutinib Chinese instructions
2026-02-01 22:25:32
Check Details
Is Acalabrutinib made by AstraZeneca?
2026-02-01 22:25:32
Check Details
Indications of Acalabrutinib
2026-02-01 22:25:32
Check Details
1
2
...
308
309
310
311
312
313
314
...
2439
2440
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves First mRNA Flu Vaccine mFLUSIVA
2
FDA Approves Orzeyful, the World's First Orexin Receptor Agonist for Narcolepsy Type 1, Ushering in a New Era of Root-Cause Therapy
3
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
4
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
5
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies
6
Phase 1 Study Progress of Ceralasertib in Combination with Durvalumab for Advanced NSCLC and HNSCC
7
Global Breakthroughs in Cancer Drugs and Advanced Treatment Technologies
8
ROS and Cancer: The Potential of Natural Antioxidants
9
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
10
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
11
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
12
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial